Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity

Biophytis SA ALBPS:

• BIOPHYTIS SA: OBTAINS EMA AUTHORIZATION TO LAUNCH ITS PHASE 2 CLINICAL TRIAL IN OBESITY - SEC FILING